SCHEMBL6645869

SCHEMBL6645869

Cc1ccc(C(=O)Nc2ccc(OCCn3cccn3)cc2)c(-c2ccc(Cl)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.50
PRKAG1 P54619 1/20 0.50
PRKAA2 P54646 1/20 0.50
PRKAA1 Q13131 1/20 0.50
PRKAG3 Q9UGI9 1/20 0.50
PRKAG2 Q9UGJ0 1/20 0.50
PRKAB1 Q9Y478 1/20 0.50
GCGR P47871 3/20 0.49
THRB P10828 1/20 0.49
MCL1 Q07820 1/20 0.46
KCNA5 P22460 1/20 0.45
AURKA O14965 2/20 0.45
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
NPC1 O15118 1/20 0.42
TSHR P16473 1/20 0.42
TP53 P04637 2/20 0.41
NR3C1 P04150 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645931 0.95 THRB (0.53) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6645076 0.92 THRB (0.50) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6645303 0.90 THRB (0.48) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6645584 0.83 HCRTR2 (0.45) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6644406 0.82 THRB (0.53) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6645791 0.81 THRB (0.52) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6501012 0.80 PPARG (0.51) GCGRAURKATAS1R3TAS1R1NPC1
SCHEMBL6647133 0.80 SMN1; SMN2 (0.47) GCGRKCNA5AURKANPC1TSHR
SCHEMBL6645353 0.79 THRB (0.51) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL6922965 0.78 THRB (0.48) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR PRKAB2 4108/4885PRKAG1 4559/4885PRKAA2 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.